Results 61 to 70 of about 6,409 (180)

Anti‑N-Methyl-D-Aspartate-Receptor Encephalitis in Young Females

Turkish Journal of Anesthesia and Reanimation, 2018
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an immune-mediated disease commonly associated with ovarian teratoma. Anti-NMDA-receptor autoantibodies disrupt NMDA function leading to the development of psychosis, seizures and autonomic dysfunction. The treatment includes underlying tumour resection and immunosuppression.
Kamlesh, Kumari, Neeru, Sahni, Vimla, Kumari, Vikas, Saini   +3 more
openaire   +2 more sources

CSF‐Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery

Annals of Neurology, Volume 99, Issue 6, Page 1468-1479, June 2026.
Objective To characterize Fc‐glycosylation profiles in patients with anti‐N‐methyl‐D‐aspartate receptor encephalitis (NMDARe) and assess their association with antibody compartmentalization (cerebrospinal fluid [CSF] vs serum), disease triggers (viral, tumor‐related or idiopathic), and 1‐year outcomes.
Laura Marmolejo, Claudia Papi, Chiara Milano, Esther Aguilar, Estibaliz Maudes, Ivana Duvnjak Orešković, Jerko Štambuk, Maja Pučić‐Baković, Gemma Olivé‐Cirera, Elianet Fonseca, Mar Guasp, Eugenia Martinez‐Hernandez, Helena Ariño, Takahiro Iizuka, Thais Armangué, Josep Dalmau, Marianna Spatola   +16 more
wiley   +1 more source

Neurocognitive Aging Following Acute Illness: Pathobiology and a Framework for Developing Neurotherapeutic Agents

Brain and Behavior, Volume 16, Issue 6, June 2026.
In this review, we discuss the scientific basis for how neurocognitive aging occurs after critical illness, including sepsis, trauma, and burns, and the clinical need to develop therapies to reduce inflammation, protect the blood–brain barrier, remove senescent cells, and enhance neuroplasticity.
Errin Lawrence, Daniel Fulton, Poppy Brown, Subashini Suresh, Mark Morris, Paraskevi Goggolidou, Sree Chaithanya, Marcus Abbawy, Amelia Wild, Prashant Nasa, Niharika A. Duggal, Fang Gao‐Smith, Zubair Ahmed, Suresh Renukappa, Tonny Veenith   +14 more
wiley   +1 more source

Encephalatrophy and anti-N-methyl-D-aspartate receptor encephalitis [PDF]

, 2020
Abstract Objective: This study aims to find whether there are differences of clinical and laboratory features between anti-NMDAR encephalitis patients with and without brain atrophy. We also compare brain atrophy scale in anti-NMDAR positive patients with and without teratomas.
Yinyao Lin, Mengyan Hu, Haiyan Li, Sanxin Liu, Xuejiao Men, Yilong Shan, Sha Tan, Xuehong Huang, Zhengqi Lu, Bingjun Zhang   +9 more
openaire   +1 more source

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Response to Early Treatment

Pediatric Neurology Briefs, 2010
A 5-year-old girl with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis and near-complete recovery following early diagnosis and treatment with immune globulin and steroids is reported from Indiana University, University of Pennsylvania, and Mayo ...
J Gordon Millichap
doaj   +1 more source

A case of non-paraneoplastic anti--methyl -aspartate receptor encephalitis presenting as a neuropsychiatric disorder

SAGE Open Medical Case Reports, 2014
N -methyl d -aspartate receptor antibody encephalitis can often be a paraneoplastic manifestation of occult malignancy such as ovarian teratoma and rarely teratoma of mediastinum or testis and small cell lung carcinoma.
Bindu Yoga, Marek Kunc, Fayyaz Ahmed
doaj   +1 more source

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee, Brian D. Adkins, Ayda Javanbakht, Hung S. Luu, Daniel K. Noland   +4 more
wiley   +1 more source

Alterations in the human gut microbiome in anti‐N‐methyl‐D‐aspartate receptor encephalitis

Annals of Clinical and Translational Neurology, 2019
Objective To explore the diversity and composition of the fecal microbiota in patients with anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis. Methods We enrolled 10 patients in the acute stage with naïve treatment, seven patients with relapse, 13 ...
Xue Gong, Xu Liu, Chen Li, Chu Chen, Jingfang Lin, Aiqing Li, Dongmei An, Dong Zhou, Zhen Hong   +8 more
doaj   +1 more source

Combination Versus Monotherapy in Acute Anti‐LGI1 Encephalitis: A Real‐World Dose Optimization Analysis

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
Combined IVIg and 500 mg/day IVMP achieve superior efficacy over monotherapies in anti‐LGI1 encephalitis, with optimal safety. Higher‐dose IVMP (1000 mg) accelerates response but increases adverse events, particularly in diabetic patients. Cognitive deficits persist post‐treatment, necessitating long‐term management.
Yao Tan, Ming Sun, Qinqin Liu, Beibei Huang, Chao Wu, Jie Lu, Donglin Zhu   +6 more
wiley   +1 more source

Anti-N-methyl-D-aspartate receptor encephalitis: analysis of three cases

Chinese Journal of Contemporary Neurology and Neurosurgery, 2018
Objective To explore the clinical features, diagnosis, treatment and prognosis of patients with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.
Ya-nan TIAN
doaj   +1 more source